Markus Tolnay

17k citations
171 papers · 14.3k · 5 hit papers · h-index 55

Impact in

  • Physiology top 0.1%
    • Alzheimer's disease research and treatments
  • Neurology top 0.2%
    • Parkinson's Disease Mechanisms and Treatments
    • Amyotrophic Lateral Sclerosis Research
    • Neuroinflammation and Neurodegeneration Mechanisms

Papers in

    • Alzheimer's disease research and treatments 67
    • Parkinson's Disease Mechanisms and Treatments 14
    • Amyotrophic Lateral Sclerosis Research 6

Markus Tolnay

166 papers receiving 13.8k citations

Markus Tolnay's Hit Papers

Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction 2020 · 955 citations
9550+6+12Years since publication4008001.2k

Peers

Markus Tolnay
Comparison fields: 5 of 144
  • Physiology 6.2k
  • Neurology 3.1k
  • Psychiatry and Mental health 1.6k
  • Neurology 464
  • Infectious Diseases 887
Replace Safa Al‐Sarraj with:
Safa Al‐Sarraj United Kingdom
Jonathan D. Glass United States
Matti Haltia Finland
Anders E. Paetau Finland
Romana Höftberger Austria
E. Tessa Hedley‐Whyte United States
Hidehiro Mizusawa Japan
Ahmet Höke United States
Pierre M. Labauge France
David Leppert Switzerland
Markus Tolnay relative to Safa Al‐Sarraj United Kingdom Safa Al‐Sarraj's profile →
Citations per field
00.5×2×2.5×
Safa Al‐Sarraj · 1×
Citations per year

Countries citing papers authored by Markus Tolnay

Since Specialization
Citations

This map shows the geographic impact of Markus Tolnay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Tolnay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Tolnay more than expected).

Fields of papers citing papers by Markus Tolnay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Tolnay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Tolnay. The network helps show where Markus Tolnay may publish in the future.

Co-authors

The 25 scholars most cited alongside Markus Tolnay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Markus Tolnay Line = papers co-authored together Markus Tolnay links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Transmission and spreading of tauopathy in transgenic mouse brain
Hit paper breakdown →
20091452
2
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
Hit paper breakdown →
2020955
3
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration
Hit paper breakdown →
2007914
4
Brain homogenates from human tauopathies induce tau inclusions in mouse brain
Hit paper breakdown →
2013609
5 2000446
6
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
Hit paper breakdown →
2015445
7 2000420
8 2014385
9 2010373
10 1999367
11 2000306
12 2012300
13 2006290
14 2015273
15 2001261
16 2007234
17 2020214
18 2013199
19 2007191
20 1999173

About Markus Tolnay

Markus Tolnay is a scholar working on Physiology, Neurology, Psychiatry and Mental health, Genetics and Molecular Biology, having authored 171 papers that have together received 14.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (67 papers), Dementia and Cognitive Impairment Research (15 papers), Parkinson's Disease Mechanisms and Treatments (14 papers), Glioma Diagnosis and Treatment (8 papers), Prion Diseases and Protein Misfolding (6 papers), Mitochondrial Function and Pathology (6 papers), Amyotrophic Lateral Sclerosis Research (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Physiology (6.2k citations), Neurology (3.1k citations), Psychiatry and Mental health (1.6k citations), Neurology (464 citations) and Infectious Diseases (887 citations). Markus Tolnay has collaborated with scholars based in Switzerland, United Kingdom and Germany. Frequent co-authors include A. Probst, Michel Goedert, Florence Clavaguera, Stephan Frank, Matthias Staufenbiel, Mathias Jucker, R. Anthony Crowther, Graham Mathew Fraser, David T. Winkler and Juergen Hench. Their work appears in journals such as Acta Neuropathologica, Neuropathology and Applied Neurobiology, Advances in experimental medicine and biology, Brain Pathology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact